As of close of business last night, Anavex Life Sciences Corporation’s stock clocked out at $4.92, down -1.80% from its previous closing price of $5.01. In other words, the price has decreased by -$0.0900 from its previous closing price. On the day, 1612059 shares were traded.
Ratios:
To gain a deeper understanding of AVXL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.85 and its Current Ratio is at 11.85. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on December 06, 2022, Downgraded its rating to Neutral and sets its target price to $11 from $16 previously.
On June 23, 2022, Berenberg started tracking the stock assigning a Buy rating and target price of $40.
On September 23, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on September 23, 2021, with a $35 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 28 when MISSLING CHRISTOPHER U sold 268,000 shares for $7.98 per share. The transaction valued at 2,139,310 led to the insider holds 1,018,210 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVXL now has a Market Capitalization of 403.99M and an Enterprise Value of 260.23M.
Stock Price History:
Over the past 52 weeks, AVXL has reached a high of $10.45, while it has fallen to a 52-week low of $4.90. The 50-Day Moving Average of the stock is 6.7782, while the 200-Day Moving Average is calculated to be 7.4313.
Shares Statistics:
It appears that AVXL traded 1.45M shares on average per day over the past three months and 1.12M shares per day over the past ten days. A total of 82.07M shares are outstanding, with a floating share count of 79.52M. Insiders hold about 3.16% of the company’s shares, while institutions hold 31.61% stake in the company. Shares short for AVXL as of Jan 31, 2024 were 20.13M with a Short Ratio of 13.87, compared to 20.07M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 24.52% and a Short% of Float of 25.33%.
Earnings Estimates
As of right now, 2 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.09 and a low estimate of -$0.13, while EPS last year was -$0.17. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.09 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.39 and -$0.57 for the fiscal current year, implying an average EPS of -$0.48. EPS for the following year is -$0.64, with 2 analysts recommending between -$0.41 and -$0.87.
